نتایج جستجو برای: fatty liver

تعداد نتایج: 420372  

Journal: :hepatitis monthly 0
chen yuan department of gastroenterology, qingdao municipal hospital, nanjing medical university, qingdao, china linlin lu digestive disease key laboratory of qingdao, qingdao, china; central laboratories, qingdao municipal hospital, qingdao, china baiquan an department of gastroenterology, qingdao municipal hospital, nanjing medical university, qingdao, china; department of gastroenterology, qingdao municipal hospital, qingdao, china wenwen jin department of gastroenterology, qingdao municipal hospital, qingdao, china quanjiang dong central laboratories, qingdao municipal hospital, qingdao, china; department of gastroenterology, qingdao municipal hospital, qingdao, china yongning xin department of gastroenterology, qingdao municipal hospital, nanjing medical university, qingdao, china; digestive disease key laboratory of qingdao, qingdao, china; department of gastroenterology, qingdao municipal hospital, qingdao, china; department of gastroenterology, qingdao municipal hospital, nanjing medical university, qingdao, china. tel: +86-53288905289, fax: +86-53288905293, e-mail:; yongning xin, department of gastroenterology, qingdao municipal hospital, nanjing medical university, qingdao, china. tel: +86-53288905289, fax: +86-53288905293

conclusions our results showed for the first time that lyplal1 gene is not associated with a risk of nafld development in the chinese han population. the variant carriers of overall subjects significantly increased weight, bmi and ldl. patients and methods lyplal1 rs12137855 gene was genotyped in 184 patients with nafld and 114 healthy controls using sequencing and polymerase chain reaction ana...

Journal: :caspian journal of internal medicine 0
seyyedabbas hashemi baqiyatallah research center for gastroenterology and liver diseases, baqiyatallah university of medical sciences, tehran, iran seyyedmoayed alavian baqiyatallah research center for gastroenterology and liver diseases, baqiyatallah university of medical sciences, tehran, iran mohammad gholami-fesharaki department of biostatistics, faculty of medical sciences, tarbiat modares university, tehran, iran.

background: transient elastography (te) is a new modality for the diagnosis of liver fibrosis caused by various etiologies. this study was conducted to determine the accuracy of te in detecting the different stages of liver fibrosis in non-alcoholic fatty liver disease (nafld) patients. methods: medline/pubmed, embase, ovid, cochrane library, american college of physicians (acp) journal club, g...

ابراهیمی دریانی, ناصر , رضامند, غلامرضا , قبائی, مژده , قدمی, هدی ,

Background: Nonalcoholic Fatty Liver Disease (NAFLD) is one of the most wide-spread human diseases that can impair liver function and sometimes progresses to cir-rhosis. Recently NAFLD has been identified as an independent risk factor for cardio-vascular disease. The aim of this study was to investigate the correlation of fatty liver disease and its sonographic severity on the resistance of the...

Introduction: Lifestyle modification through dietary interventions and exercise training is the main approach to treating nonalcoholic fatty liver (NAFLD). The aim of this study was to investigate the effect of high-intensity interval training (HIIT) with Portulaca oleracea supplementation on liver X receptor α (LXRα) and peroxisome proliferator-activated receptor γ (PPARγ) in the liver tissue ...

Ali Zarei Azam Rezaei Saeed Changizi Ashtiyani, Saeed Zaheiri Soheila Taheri

Objectives: Hyperlipidemia can cause a variety of diseases such as atherosclerosis, diabetes, and fatty liver which is followed by increased liver enzymes. Since Berberis vulgaris (B. vulgaris) root possesses antioxidant properties, the present study was conducted to investigate the effect ofits extract on the activity of liver enzymes in rats. Materials and Methods: In this experimental study...

Parvin Dehghan, Sodeif Azadmard-Damirchi, Vali Musazadeh,

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease (CLD). Omega-3 fatty acids and antioxidants co-supplementation have been considered as an alternative treatment in NAFLD. This trial will evaluate camelina sativa oil (CSO) effects as a rich source of omega-3 fatty acids and antioxidants on cardiometabolic risk factors, metabolic endotoxemia, liver en...

Journal: :Endocrine journal 2017
Kazuteru Mitsuhashi Yoshitaka Hashimoto Masahide Hamaguchi Akihiro Obora Takao Kojima Takuya Fukuda Michiaki Fukui

Fatty liver disease and metabolic syndrome (MetS) are both shown to increase the risk of type 2 diabetes. The aim of this study was to investigate the combined effect of fatty liver and MetS on incident diabetes. In this cohort study of 17,810 participants, fatty liver was diagnosed by abdominal ultrasonography and MetS was defined by a joint interim statement. We divided the participants into ...

تیموری, ناهید, نیری, هاشم,

Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease is increasing in adults and children worldwide. Obesity, insulin resistance or diabetes type II, hyperlipidemia and hypertriglyceridemia plays a major role in the epidemiology of this disease. Cytokeratin 18 (CK-18) the major intermediate filament protein in the liver is a marker of increased hepatocyte apoptosis. ...

Introduction: Interleukin 18 (IL-18) is a member of the cytokine family and an important regulator of inflammatory reactions. Due to the severe and irreversible complications of this disease in the advanced stages, timely treatment, especially with herbal medicines, can be considered an important strategy. This study aimed to investigate the effect of grapefruit extract on the IL-18 gene expres...

Journal: :Clinical hypertension 2015
Eun Na Han Eun Sun Cheong Jeong In Lee Min Chul Kim Christopher D Byrne Ki-Chul Sung

INTRODUCTION Fatty liver is associated with metabolic syndrome (MetS) but it may also occur without MetS. Whether resolution of fatty liver in the general population affects risk of MetS is unknown. Our aim was to determine whether a change in fatty liver status (either the development of new fatty liver or the resolution of existing fatty liver) would modify the risk of de novo MetS. METHODS...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید